Discovery of Natural Compounds as SARS-CoV-2’s Main Protease Inhibitors by Docking-based Virtual Screening. (2023). Letters in Drug Design & Discovery, 21(10), 1604-1610. https://journal.international-life-sciences.com/index.php/lddd/article/view/48